• STUDIES
    Participation is open to worldwide institutions.
    Read More
  • MEETINGS
    Since 1998, an Annual Meeting of the IELSG investigators has been regularly held.
    Read More
  • NEWSLETTER
    The IELSG Newsletter informs about studies, meetings and other research activities.
    Read More
  • PUBLICATIONS
    The results are presented to major congresses and published into peer-reviewed journals.
    Read More

Fighting cancer through research. You can support us by making a donation, however large or small.

Support Us

LATEST NEWS

  • IELSG43 – Consolidation therapy for primary CNS lymphoma (PCNSL)
    Reference High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial. Lancet. 2026 Jul 22:S0140-6736(26)00917-7. doi: 10.1016/S0140-6736(26)00917-7. Link
    Author(s) Illerhaus G, Ferreri AJM, Wendler J, Binder M, Borchmann P, Hasenkamp J, Stilgenbauer S, Röth A, Egerer G, Ernst T, Weber T, Hertenstein B, Lenz G, Dreyling M, Möhle R, Kobbe G, Schmidt CA, Brunnberg U, Panse J, Kneba M, Heinicke T, Schroll S, Larsen TS, Thurner L, Pukrop T, Salwender H, Naumann R, Hess G, Kroschinsky FP, Blystad AK, Keller U, Pulczynski EJ, Pedersen MB, Re F, Orsucci L, Pospiech L, La Rosée P, Deckert M, Ponzoni M, Gmehlin D, Backenstrass M, Jensch A, Valk E, Calimeri T, Kasenda B, Trepel M, Fricker H, Semenova I, Scherer F, von Gottberg P, Burger E, Grishina O, Hader C, Ihorst G, Finke J, Zucca E, Schorb E.
    Study IELSG43

  • IELSG37 – New evidence supporting the prognostic value of PET-derived radiomics in PMBCL
    Reference Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study. Br J Haematol. 2026 Jun 16. doi: 10.1111/bjh.70614. Link
    Author(s) Ceriani L, Milan L, Cascione L, Di Rocco A, Kryachok I, Davies AJ, Stathis A, Rossi D, Johnson PWM, Martelli M, Zucca E.
    Study IELSG37

ONGOING STUDIES

  • IELSG57
    IELSG57Characterization of primary central nervous system diffuse large B cell lymphoma (PCNS-DLBCL) by multiomic approachSamples requiredat least 100 patientsInvestigator responsible(s)M. Paulli, M.… Read more: IELSG57
  • IELSG56
    IELSG56 Molecular and cellular characterization of MALT lymphoma across anatomical sites: Integrative transcriptomic and epigenetic approaches Samples required 300-500 Investigator responsible(s) L.… Read more: IELSG56
  • IELSG55
    IELSG55 Real world data analysis of the first line immunochemotherapy regimens assessing R-CHOP-14 efficacy in primary mediastinal B-cell lymphoma patients. Samples required… Read more: IELSG55

LATEST NEWSLETTER

PUBLICATIONS

Studies

Extranodal NHLs can arise from a variety of anatomical districts. Participation is open to worldwide institutions. For further information about the clinical trials, please contact us. ...

Read More

Publications

The results of the IELSG studies are presented to major international congresses and sent for publication to major peer-reviewed journals.

Read More

Donations

The IELSG is as a branch of the Foundation for the Institute of Oncology Research and develops non-profit and independent scientific research projects to improve the knowledge and the treatm...

Read More

Meetings

Since 1998, an Annual Meeting of the IELSG investigators is held. The meeting aims to bring together physicians and scientists from all over the world to present and discuss the ongoi...

Read More
Top